Tyra Biosciences, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Tyra Biosciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q3 2024.
  • Tyra Biosciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $7.57M, a 73% increase year-over-year.
  • Tyra Biosciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $20.3M, a 65.6% increase year-over-year.
  • Tyra Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13.5M, a 27.7% increase from 2022.
  • Tyra Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $10.6M, a 267% increase from 2021.
  • Tyra Biosciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $2.89M, a 558% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $20.3M $7.57M +$3.2M +73% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $17.1M $4.41M +$1.88M +74.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $15.2M $4.12M +$1.68M +69.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $13.5M $4.19M +$1.28M +43.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-19
Q3 2023 $12.2M $4.38M +$3.36M +330% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $8.89M $2.53M -$158K -5.88% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $9.05M $2.43M -$1.54M -38.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $10.6M $2.91M +$1.04M +55.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-19
Q3 2022 $9.55M $1.02M +$511K +101% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $9.03M $2.69M +$2.35M +695% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $6.69M $3.97M +$3.8M +2183% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $2.89M $1.87M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $508K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $338K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $174K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.